Hrain Biotechnology Co., Ltd.
Privately held: no public share price
Assets
(4 total)
4Total Assets
0Approved
0Phase 3 / Filed
4Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 2 | BCMACell therapy | Multiple Myeloma | |
| Phase 2 | BCMACell therapy | Multiple Myeloma | |
| Phase 1 | FLT3Cell therapy | Acute Myeloid Leukemia | |
| Phase 1 | BCMACell therapy | Multiple Myeloma |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.